US Stock MarketDetailed Quotes
PIRS Pieris Pharmaceuticals
- 16.4300
- +0.1752+1.08%
Close Dec 2 16:00 ET
- 16.4300
- 0.00000.00%
Post 20:02 ET
21.69MMarket Cap-1356P/E (TTM)
17.0000High16.3100Low34.50KVolume16.4000Open16.2548Pre Close571.79KTurnover4.55%Turnover RatioLossP/E (Static)1.32MShares22.320052wk High1.33P/B12.47MFloat Cap6.200052wk Low--Dividend TTM758.84KShs Float780.0000Historical High--Div YieldTTM4.25%Amplitude6.2000Historical Low16.5720Avg Price1Lot Size
About Pieris Pharmaceuticals Company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
Company Profile
SymbolPIRS
Company NamePieris Pharmaceuticals
Listing DateJun 30, 2015
Issue Price3.12
Founded2001
CEOMr. Stephen S. Yoder
MarketNASDAQ
Employees50
Fiscal Year Ends12-31
Address225 Franklin Street,9th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-857-246-8998
Websitehttp://www.pieris.com
Company Executives
- Name
- Position
- Salary
- Stephen S. Yoder
- Chief Executive Officer, President and Director
- 1.36M
- Thomas Bures
- Principal Accounting Officer, Senior Vice President and Chief Financial Officer
- 729.04K
- James A. Geraghty
- Chairman of the Board
- 94.09K
- Christopher Kiritsy
- Independent Director
- 72.58K
- Dr. Peter A. Kiener, D.Phil.
- Independent Director
- 65.08K
- Dr. Maya R. Said, Sc.D.
- Independent Director
- 52.09K
- Michael S. Richman
- Independent Director
- 52.09K
- Dr. Matthew L. Sherman, M.D.
- Independent Director
- 53.09K
- Dr. Ann Barbier, M.D.,PhD
- Independent Director
- 52.09K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data